Sonnet BioTherapeutics Holdings, Inc.
SONN · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $321 | $2,059 | $4,862 | $149 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $597 | $778 | $667 | $762 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $401 | $421 | $1,197 | $0 |
| Total Curr. Assets | $1,320 | $3,258 | $6,725 | $2,118 |
| Property Plant & Equip (Net) | $77 | $100 | $122 | $144 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $658 | $479 | $335 | $509 |
| Total NC Assets | $736 | $578 | $457 | $653 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,055 | $3,836 | $7,182 | $2,771 |
| Liabilities | – | – | – | – |
| Payables | $3,750 | $1,745 | $1,640 | $2,183 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,283 | $2 | $157 | $152 |
| Total Curr. Liab. | $5,102 | $3,174 | $3,122 | $3,210 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $24 | $47 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $69 | $90 | $111 | $131 |
| Total Liabilities | $5,102 | $3,174 | $3,145 | $3,257 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$128,109 | -$124,333 | -$120,842 | -$117,681 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$3,046 | $662 | $4,037 | -$486 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,055 | $3,836 | $7,182 | $2,771 |
| Net Debt | -$321 | -$2,059 | -$4,862 | -$149 |